SeekingAlpha · Aug 26, 2026
Stantec: Organic Growth Acceleration And A Discounted Valuation Support A Buy
Stantec (STN) is a Buy: record C$9.2B backlog, undervalued multiples, H2 2026 growth catalysts, and margin upside. Read here for a detailed analysis.

